001     201294
005     20240625095127.0
024 7 _ |2 doi
|a 10.1021/ct300167m
024 7 _ |2 ISSN
|a 1549-9618
024 7 _ |2 ISSN
|a 1549-9626
024 7 _ |2 WOS
|a WOS:000307478800039
024 7 _ |a altmetric:821290
|2 altmetric
037 _ _ |a FZJ-2015-03599
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Nguyen, Trung Hai
|b 0
245 _ _ |a Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach
260 _ _ |a Washington, DC
|b American Chemical Society (ACS)
|c 2012
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1433838424_26778
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a The cellular uptake of cisplatin and of other platinum-based drugs is mediated by the high-affinity copper transporter Ctr1. The eight-residue long peptide called Mets7 (MTGMKGMS) mimics one of extracellular methionine (Met)-rich motifs of Ctr1. It is an excellent model for investigating the interaction of platinum drugs with Ctr1 under in vitro and in vivo conditions. Some of us have shown that (i) Cisplatin loses all of its ligands upon reaction with Mets7 and the metal ion binds to the three Met residues and completes its coordination shell with a fourth ligand that can be a chloride or a water/hydroxyl oxygen. (ii) Transplatin loses only the chlorido ligands, which are replaced by Met residues. Here, we provide information on the structural determinants of cisplatin/Mets7 and transplatin/Mets7 adducts by computational methods. The predictions are validated against EXAFS, NMR, and CD spectra. While EXAFS gives information restricted to the metal coordination shell, NMR provides information extended to residue atoms around the coordination shell, and finally, CD provides information about the overall conformation of the peptide. This allows us to elucidate the different reaction modes of cisplatin and transplatin toward the peptide, as well as to propose the platinated peptides [PtX]+−(M*TGM*KGM*S) (X = Cl−, OH− ) and trans[Pt(NH3)2]2+−(M*TGM*KGMS) as the most relevant species occurring in water solution.
536 _ _ |0 G:(DE-HGF)POF2-899
|a 899 - ohne Topic (POF2-899)
|c POF2-899
|x 0
|f POF I
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Arnesano, Fabio
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Scintilla, Simone
|b 2
700 1 _ |0 P:(DE-Juel1)145921
|a Rossetti, Giulia
|b 3
|u fzj
700 1 _ |0 P:(DE-Juel1)146009
|a Ippoliti, Emiliano
|b 4
|u fzj
700 1 _ |0 P:(DE-Juel1)145614
|a Carloni, Paolo
|b 5
|e Corresponding Author
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Natile, Giovanni
|b 6
|e Corresponding Author
773 _ _ |0 PERI:(DE-600)2166976-4
|a 10.1021/ct300167m
|g Vol. 8, no. 8, p. 2912 - 2920
|n 8
|p 2912 - 2920
|t Journal of chemical theory and computation
|v 8
|x 1549-9626
|y 2012
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201294/files/ct300167m.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:201294
|p VDB
910 1 _ |0 I:(DE-588b)1026307295
|6 P:(DE-HGF)0
|a German Research School for Simulation Sciences
|b 0
|k GRS
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145921
|a Forschungszentrum Jülich GmbH
|b 3
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)146009
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145614
|a Forschungszentrum Jülich GmbH
|b 5
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-899
|1 G:(DE-HGF)POF3-890
|2 G:(DE-HGF)POF3-800
|a DE-HGF
|b Forschungsbereich Materie
|l Forschungsbereich Materie
|v ohne Topic
|x 0
913 1 _ |0 G:(DE-HGF)POF2-899
|1 G:(DE-HGF)POF2-890
|2 G:(DE-HGF)POF2-800
|a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)GRS-20100316
|k GRS
|l GRS
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)GRS-20100316
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-9-20140121
981 _ _ |a I:(DE-Juel1)IAS-5-20120330


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21